NDC 50090-3011-01 - ACETAMINOPHEN AND CODEINE PHOSPHATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-3011
- Requested NDC
- 50090-3011-01
- Package NDCs from labels
- 50090-3011-7, 50090-3011-4, 50090-3011-5, 50090-3011-2, 50090-3011-8, 50090-3011-6, 50090-3011-3, 50090-3011-0, 50090-3011-1, 50090-3011-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN AND CODEINE PHOSPHATE - A-S Medication Solutions | A-S Medication Solutions | 2026-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3011-0 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 20 in 1 BOTTLE | TABLET | 20 | 18 | |
| 50090-3011-1 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 30 in 1 BOTTLE | TABLET | 30 | 18 | |
| 50090-3011-2 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 90 in 1 BOTTLE | TABLET | 90 | 18 | |
| 50090-3011-3 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 100 in 1 BOTTLE | TABLET | 100 | 18 | |
| 50090-3011-4 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 50 in 1 BOTTLE | TABLET | 50 | 18 | |
| 50090-3011-5 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 40 in 1 BOTTLE | TABLET | 40 | 18 | |
| 50090-3011-6 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 15 in 1 BOTTLE | TABLET | 15 | 18 | |
| 50090-3011-7 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 12 in 1 BOTTLE | TABLET | 12 | 18 | |
| 50090-3011-8 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 60 in 1 BOTTLE | TABLET | 60 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3011 | ACETAMINOPHEN AND CODEINE PHOSPHATE TABLET [A-S MEDICATION SOLUTIONS] | 14 | Current NDC, Legacy NDC, 9 package rows | 20250403_9ca1321e-380a-48d7-8a58-c6501858c1c0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3011-1 | EA - Each | 50090-3011 | e01359d6-f3e7-4650-93fd-9716610e712c | 1 | 2019-05-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Target Maximum Strength Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORPORATION | 1d3ad31f-ef4d-45ba-a6e3-13d66b51d1d2 | 2026-11-10 | Warnings | 362O9ITL9D |
| Cold Max | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | AmeriSource Bergen | 608e6808-29e4-40bc-8496-24c092681a1b | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 39800c27-f39f-cd60-e063-6394a90acd55 | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | SAFEWAY | d2d15e06-e9eb-3d2b-e053-2995a90a1cec | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Safeway | f9597abc-3f01-4b94-8078-228e0b74677e | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief (Arthritis) | PAIN RELIEF (ARTHRITIS) | Demoulas Super Markets, Inc. | 14a2abd2-0e64-4a8b-a979-cc19a3dbd525 | 2026-11-09 | Warnings | 362O9ITL9D |
| equate pain reliever | ACETAMINOPHEN, IBUPROFEN | WALMART INC. | 8e0aaae0-a97d-4b9d-b326-44ef45f3fa0c | 2026-11-08 | Warnings | 362O9ITL9D |
| Target Overnight Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, TRIPROLIDINE HCL | TARGET CORPORATION | 05e944d5-3473-4d8c-8df4-2ffc7474e9fa | 2026-11-06 | Warnings | 362O9ITL9D |
| Vicks NyQuil VapoCOOL COLD and FLU | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 32819305-9bbd-8843-e063-6294a90a7f2e | 2026-11-06 | Warnings | 362O9ITL9D |
| Children Pain and Fever Reliever | ACETAMINOPHEN | Target Corporation | 0dd643a4-3cbc-423d-95b4-ba373b09d895 | 2026-11-06 | Warnings | 362O9ITL9D |
| Children Pain and Fever Reliver | ACETAMINOPHEN | Target Corporation | 1116f808-f61e-47ec-b0d0-d4be5aa905be | 2026-11-06 | Warnings | 362O9ITL9D |
| Tukol Childrens Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA | aa685658-953e-4307-996c-ee39ca6bf9ba | 2026-11-06 | Warnings | 362O9ITL9D |
| Sinus Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | f701a6ae-200d-48dc-94e4-6bd3228f50d4 | 2026-11-05 | Warnings | 362O9ITL9D |
| Foster and Thrive Regular Strength Pain Relief Acetaminophen 325mg | ACETAMINOPHEN 325MG | STRATEGIC SOURCING SERVICES LLC | 58780980-a5b2-5d1f-e063-6294a90a5a92 | 2026-11-05 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | American Health Packaging | 03c9ff0d-46e8-448c-944a-7ad59d1afd6d | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Caffeine | ACETAMINOPHEN AND CAFFEINE | HHH Pharmaceuticals | 6f5bfd54-b366-46ac-aafa-394e21ce8de6 | 2026-11-05 | Warnings | 362O9ITL9D |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | e0dd4c04-6811-38a1-e053-2995a90aa3c9 | 2026-11-05 | Warnings | 362O9ITL9D |
| Tesalon Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAFEISIN USP, PHENYLEPHRINE HCL | OPMX LLC | 2309620a-ccbc-41e9-e063-6394a90a9520 | 2026-11-05 | Warnings | 362O9ITL9D |
| Childrens Pain and Fever | ACETAMINOPHEN | Walgreen Company | a482e715-bec0-44a4-bb0e-ea5f5fda558e | 2026-11-05 | Warnings | 362O9ITL9D |
| DayQuil Severe plus Vicks VapoCool Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | 724f2833-34bd-6a9e-e053-2991aa0a073d | 2026-11-04 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.